Abcam plc
Abcam Limited, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. The company's principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and vario… Read more
Abcam plc (ABCZF) - Net Assets
Latest net assets as of June 2023: $719.20 Million USD
Based on the latest financial reports, Abcam plc (ABCZF) has net assets worth $719.20 Million USD as of June 2023.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($1.03 Billion) and total liabilities ($307.90 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $719.20 Million |
| % of Total Assets | 70.02% |
| Annual Growth Rate | 41.6% |
| 5-Year Change | 106.68% |
| 10-Year Change | 326.89% |
| Growth Volatility | 81.33 |
Abcam plc - Net Assets Trend (2002–2022)
This chart illustrates how Abcam plc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Abcam plc (2002–2022)
The table below shows the annual net assets of Abcam plc from 2002 to 2022.
| Year | Net Assets | Change |
|---|---|---|
| 2022-12-31 | $726.90 Million | +10.79% |
| 2021-12-31 | $656.10 Million | +30.54% |
| 2019-12-31 | $502.60 Million | +30.61% |
| 2018-12-31 | $384.80 Million | +9.41% |
| 2017-12-31 | $351.70 Million | +14.52% |
| 2016-12-31 | $307.12 Million | +17.58% |
| 2015-12-31 | $261.19 Million | +21.99% |
| 2014-12-31 | $214.10 Million | +18.35% |
| 2013-12-31 | $180.90 Million | +6.24% |
| 2012-12-31 | $170.28 Million | +14.89% |
| 2011-12-31 | $148.21 Million | +100.50% |
| 2010-12-31 | $73.92 Million | +38.89% |
| 2009-12-31 | $53.22 Million | +45.94% |
| 2008-12-31 | $36.47 Million | +51.18% |
| 2007-12-31 | $24.12 Million | +27.72% |
| 2006-12-31 | $18.89 Million | +25.35% |
| 2005-12-31 | $15.07 Million | +368.65% |
| 2004-12-31 | $3.21 Million | +94.61% |
| 2003-12-31 | $1.65 Million | +138.73% |
| 2002-12-31 | $692.00K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Abcam plc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 30111100000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2022)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $300.70 Million | 41.37% |
| Common Stock | $500.00K | 0.07% |
| Other Comprehensive Income | $158.20 Million | 21.76% |
| Other Components | $267.50 Million | 36.80% |
| Total Equity | $726.90 Million | 100.00% |
Abcam plc Competitors by Market Cap
The table below lists competitors of Abcam plc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
RLI Corp
NYSE:RLI
|
$5.00 Billion |
|
Sensata Technologies Holding NV
NYSE:ST
|
$5.00 Billion |
|
Riot Blockchain Inc
NASDAQ:RIOT
|
$5.01 Billion |
|
Bim Birlesik Magazalar
PINK:BMBRF
|
$5.01 Billion |
|
Gamuda Bhd
KLSE:5398
|
$5.00 Billion |
|
Knorr-Bremse Aktiengesellschaft
PINK:KNBHF
|
$5.00 Billion |
|
Shenzhou International Group Holdings Limited
PINK:SHZHY
|
$5.00 Billion |
|
Hongda
SHG:600331
|
$4.99 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Abcam plc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2021 to 2022, total equity changed from 656,100,000 to 726,900,000, a change of 70,800,000 (10.8%).
- Net loss of 8,500,000 reduced equity.
- Share repurchases of 200,000 reduced equity.
- New share issuances of 1,100,000 increased equity.
- Other comprehensive income increased equity by 58,300,001.
- Other factors increased equity by 20,099,999.
Equity Change Factors (2021 to 2022)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-8.50 Million | -1.17% |
| Share Repurchases | $200.00K | -0.03% |
| Share Issuances | $1.10 Million | +0.15% |
| Other Comprehensive Income | $58.30 Million | +8.02% |
| Other Changes | $20.10 Million | +2.77% |
| Total Change | $- | 10.79% |
Book Value vs Market Value Analysis
This analysis compares Abcam plc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 7.08x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 5534.85x to 7.08x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2002-12-31 | $0.00 | $22.25 | x |
| 2003-12-31 | $0.01 | $22.25 | x |
| 2004-12-31 | $0.02 | $22.25 | x |
| 2005-12-31 | $0.09 | $22.25 | x |
| 2006-12-31 | $0.11 | $22.25 | x |
| 2007-12-31 | $0.14 | $22.25 | x |
| 2008-12-31 | $0.20 | $22.25 | x |
| 2009-12-31 | $0.29 | $22.25 | x |
| 2010-12-31 | $0.40 | $22.25 | x |
| 2011-12-31 | $0.79 | $22.25 | x |
| 2012-12-31 | $0.85 | $22.25 | x |
| 2013-12-31 | $0.90 | $22.25 | x |
| 2014-12-31 | $1.06 | $22.25 | x |
| 2015-12-31 | $1.29 | $22.25 | x |
| 2016-12-31 | $1.50 | $22.25 | x |
| 2017-12-31 | $1.71 | $22.25 | x |
| 2018-12-31 | $1.86 | $22.25 | x |
| 2019-12-31 | $2.40 | $22.25 | x |
| 2021-12-31 | $3.16 | $22.25 | x |
| 2022-12-31 | $3.14 | $22.25 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Abcam plc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -1.17%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -2.35%
- • Asset Turnover: 0.34x
- • Equity Multiplier: 1.45x
- Recent ROE (-1.17%) is below the historical average (25.48%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2002 | 74.71% | 14.75% | 3.15x | 1.61x | $447.80K |
| 2003 | 61.08% | 15.00% | 2.35x | 1.73x | $843.80K |
| 2004 | 70.95% | 18.80% | 2.23x | 1.69x | $1.96 Million |
| 2005 | 22.73% | 17.69% | 1.07x | 1.21x | $1.92 Million |
| 2006 | 21.50% | 16.56% | 1.07x | 1.21x | $2.17 Million |
| 2007 | 24.42% | 16.09% | 1.26x | 1.20x | $3.48 Million |
| 2008 | 33.70% | 21.64% | 1.26x | 1.24x | $8.64 Million |
| 2009 | 36.12% | 27.03% | 1.12x | 1.19x | $13.90 Million |
| 2010 | 32.20% | 28.59% | 0.96x | 1.17x | $16.41 Million |
| 2011 | 17.14% | 25.97% | 0.56x | 1.19x | $10.58 Million |
| 2012 | 19.18% | 26.72% | 0.61x | 1.17x | $15.63 Million |
| 2013 | 18.82% | 26.61% | 0.62x | 1.14x | $15.96 Million |
| 2014 | 17.46% | 25.96% | 0.58x | 1.17x | $15.97 Million |
| 2015 | 14.33% | 21.80% | 0.52x | 1.26x | $11.31 Million |
| 2016 | 13.79% | 19.51% | 0.60x | 1.18x | $11.65 Million |
| 2017 | 17.69% | 26.67% | 0.56x | 1.18x | $27.03 Million |
| 2018 | 11.69% | 17.31% | 0.58x | 1.16x | $6.52 Million |
| 2019 | 2.49% | 4.81% | 0.32x | 1.61x | $-37.76 Million |
| 2021 | 0.67% | 1.40% | 0.32x | 1.50x | $-61.21 Million |
| 2022 | -1.17% | -2.35% | 0.34x | 1.45x | $-81.19 Million |
Industry Comparison
This section compares Abcam plc's net assets metrics with peer companies in the same industry.
Industry Context
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Abcam plc (ABCZF) | $719.20 Million | 74.71% | 0.43x | $5.00 Billion |
| Able View Global Inc. Warrant (ABLVW) | $11.42 Million | 85.41% | 3.81x | $277.93K |
| Above Food Ingredients Inc. Warrants (ABVEW) | $199.86 Million | -2.89% | 0.00x | $6.25 Million |
| Adamas Trust, Inc. (ADAMG) | $2.43 Billion | 7.94% | 1.33x | $2.09 Billion |
| ADS-TEC ENERGY PLC Warrant (ADSEW) | $33.92 Million | -162.39% | 2.67x | $10.06 Million |
| Alliance Entertainment Holding Corporation Warrants (AENTW) | $52.92 Million | 10.13% | 4.23x | $2.29 Million |
| Forafric Global PLC Warrants (AFRIW) | $5.32 Million | -457.58% | 45.29x | $2.67 Million |
| Centurion Acquisition Corp. Warrant (ALFUW) | $282.84 Million | 1.97% | 0.05x | $4.81 Million |
| Alliance Trust PLC (ALITF) | $4.04 Billion | 10.04% | 0.29x | $112.87K |
| Alvotech Warrant (ALVOW) | $-564.42 Million | 0.00% | 0.00x | $35.01 Million |